Literature DB >> 1318272

A single human colonic adenoma cell line can be converted in vitro to both a colorectal adenocarcinoma and a mucinous carcinoma.

C Paraskeva1, A Hague, N Rooney, A C Williams, S J Harper, K A Hanlon, R J Atkinson, A P Corfield.   

Abstract

In a previous study, using a chemical carcinogen, we converted in vitro a non-tumorigenic cell line derived from a human colorectal diploid adenoma, designated PC/AA, into a tumorigenic cell line which, when inoculated into athymic nude mice, produced progressively growing adenocarcinomas. We now report that continuous in vitro passage of the PC/AA adenoma cell line resulted in its spontaneous transformation to a mucinous carcinoma with a modal karyotype of 51, XY, +i(Iq), +8, +9, +13, +i(13q), -21, +mar. These studies show that a single adenoma can be converted along 2 independent pathways, giving rise to either a mucinous carcinoma or an adenocarcinoma, and provide further experimental evidence for the adenoma-carcinoma sequence. Cytogenetic changes which occur along both pathways to tumorigenicity include abnormalities of chromosome I and multiple copies of chromosome 13. These abnormalities may be important in tumour development and progression in colorectal carcinogenesis.

Entities:  

Mesh:

Year:  1992        PMID: 1318272     DOI: 10.1002/ijc.2910510426

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  2 in total

1.  Reduction of sialic acid O-acetylation in human colonic mucins in the adenoma-carcinoma sequence.

Authors:  A P Corfield; N Myerscough; B F Warren; P Durdey; C Paraskeva; R Schauer
Journal:  Glycoconj J       Date:  1999-06       Impact factor: 2.916

2.  A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor gene.

Authors:  S D Markowitz; L Myeroff; M J Cooper; J Traicoff; M Kochera; J Lutterbaugh; M Swiriduk; J K Willson
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.